PEAK6 Group’s Phibro Animal Health PAHC Stock Holding History

PEAK6 Group’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,000	Closed	-$127K	–	5157
2015 Q3	$127K	Buy	+4,000	New	+$146K	﹤0.01%	4139

Other funds holding PAHC

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FIM

Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

PIM

Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

PEAK6 Group's PAHC Position: Q4 2015 in Review

PEAK6 Group sold out of Phibro Animal Health (PAHC) in Q4 2015, closing a stake of 3,131 shares — an estimated $99K sold.

PEAK6 Group first reported a position in PAHC in Q3 2015 and held it in 1 quarter. The position peaked at $99K in Q3 2015. 124 funds tracked by Wall St. Rank hold PAHC as of Q4 2015.

PEAK6 Group reported no remaining Phibro Animal Health position as of Q4 2015 after selling out during the quarter.
PEAK6 Group sold 3,131 Phibro Animal Health shares in Q4 2015, an estimated $99K.
PEAK6 Group first reported a position in Phibro Animal Health in Q3 2015 and held it in 1 quarter.
PEAK6 Group's Phibro Animal Health position peaked at $99K in Q3 2015.
124 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2015.

Based on PEAK6 Group's 13F filing for Q4 2015, filed 16 Feb 2016.